Skip to main content
. 2014 Sep 15;9(18):1688–1695. doi: 10.4103/1673-5374.141804

Figure 3.

Figure 3

Protein phosphatase 2A (PP2A) affected the targeted migration of bone marrow mesenchymal stem cells (BMSCs) during treatment of ischemic spinal cord injury (confocal laser scanning microscope).

PP2A inhibitor and agonist delayed BMSC migration. There were fewer BMSCs in the inhibitor and agonist groups than in the BMSC group. Arrows show transplanted BMSCs. Red: CM-DiI-labeled cells. Scale bar: 100 μm. d: Days.